
Gerald R. Ewoldt
Examiner (ID: 4358, Phone: (571)272-0843 , Office: P/1644 )
| Most Active Art Unit | 1644 |
| Art Unit(s) | 1644 |
| Total Applications | 1060 |
| Issued Applications | 256 |
| Pending Applications | 142 |
| Abandoned Applications | 661 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16075595
[patent_doc_number] => 20200191784
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => BIOMARKER COMPOSITION FOR DIAGNOSIS OF SYSTEMIC LUPUS ERYTHEMATOSUS COMPRISING AIMP1 AND METHOD FOR DIAGNOSING SYSTEMIC LUPUS ERYTHEMATOSUS USING SAME
[patent_app_type] => utility
[patent_app_number] => 16/608931
[patent_app_country] => US
[patent_app_date] => 2018-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3960
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16608931
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/608931 | BIOMARKER COMPOSITION FOR DIAGNOSIS OF SYSTEMIC LUPUS ERYTHEMATOSUS COMPRISING AIMP1 AND METHOD FOR DIAGNOSING SYSTEMIC LUPUS ERYTHEMATOSUS USING SAME | Apr 29, 2018 | Abandoned |
Array
(
[id] => 17096960
[patent_doc_number] => 20210284751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => METHODS AND ANTIBODIES FOR DIABETES-RELATED APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 16/606887
[patent_app_country] => US
[patent_app_date] => 2018-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36684
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16606887
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/606887 | Anti-CD59 antibodies | Apr 16, 2018 | Issued |
Array
(
[id] => 16482428
[patent_doc_number] => 20200376028
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => Methods and Compounds for Treating Diabetes
[patent_app_type] => utility
[patent_app_number] => 16/603438
[patent_app_country] => US
[patent_app_date] => 2018-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10155
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16603438
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/603438 | Methods and Compounds for Treating Diabetes | Apr 9, 2018 | Abandoned |
Array
(
[id] => 16665121
[patent_doc_number] => 10934354
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-02
[patent_title] => Methods of increasing T cell immune response in the treatment of cancer
[patent_app_type] => utility
[patent_app_number] => 15/942168
[patent_app_country] => US
[patent_app_date] => 2018-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 17
[patent_no_of_words] => 18048
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15942168
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/942168 | Methods of increasing T cell immune response in the treatment of cancer | Mar 29, 2018 | Issued |
Array
(
[id] => 16720099
[patent_doc_number] => 20210087246
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => MULTIPLE SCLEROSIS ASSOCIATED AUTOANTIGENS, AND USE THEREOF IN THERAPY AND DIAGNOSIS
[patent_app_type] => utility
[patent_app_number] => 16/498954
[patent_app_country] => US
[patent_app_date] => 2018-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18512
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16498954
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/498954 | MULTIPLE SCLEROSIS ASSOCIATED AUTOANTIGENS, AND USE THEREOF IN THERAPY AND DIAGNOSIS | Mar 28, 2018 | Abandoned |
Array
(
[id] => 15646683
[patent_doc_number] => 20200085871
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-19
[patent_title] => METHODS OF USING CYTOTOXIC T CELLS FOR TREATMENT OF AUTOIMMUNE DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/494484
[patent_app_country] => US
[patent_app_date] => 2018-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31773
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16494484
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/494484 | METHODS OF USING CYTOTOXIC T CELLS FOR TREATMENT OF AUTOIMMUNE DISEASES | Mar 18, 2018 | Abandoned |
Array
(
[id] => 15264873
[patent_doc_number] => 20190381170
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR AUTOIMMUNE DISEASE, AND VACCINE
[patent_app_type] => utility
[patent_app_number] => 16/489108
[patent_app_country] => US
[patent_app_date] => 2018-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6410
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16489108
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/489108 | PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR AUTOIMMUNE DISEASE, AND VACCINE | Feb 25, 2018 | Abandoned |
Array
(
[id] => 15863125
[patent_doc_number] => 20200138966
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => BIFUNCTIONAL SMALL PEPTIDE FOR AUTOIMMUNE DIABETES
[patent_app_type] => utility
[patent_app_number] => 16/480708
[patent_app_country] => US
[patent_app_date] => 2018-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9195
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16480708
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/480708 | BIFUNCTIONAL SMALL PEPTIDE FOR AUTOIMMUNE DIABETES | Jan 28, 2018 | Abandoned |
Array
(
[id] => 18070581
[patent_doc_number] => 11529397
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-20
[patent_title] => Method of treating mucopolysaccharidosis type IVA
[patent_app_type] => utility
[patent_app_number] => 15/876892
[patent_app_country] => US
[patent_app_date] => 2018-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 13364
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15876892
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/876892 | Method of treating mucopolysaccharidosis type IVA | Jan 21, 2018 | Issued |
Array
(
[id] => 15150349
[patent_doc_number] => 20190353652
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-21
[patent_title] => Method for Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy
[patent_app_type] => utility
[patent_app_number] => 16/477013
[patent_app_country] => US
[patent_app_date] => 2018-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6530
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16477013
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/477013 | Method for Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy | Jan 11, 2018 | Abandoned |
Array
(
[id] => 12702301
[patent_doc_number] => 20180125933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-10
[patent_title] => INSULIN INDEPENDENCE AMONG PATIENTS WITH DIABETES UTILIZING AN OPTIMIZED HAMSTER REG3 GAMMA PEPTIDE
[patent_app_type] => utility
[patent_app_number] => 15/854554
[patent_app_country] => US
[patent_app_date] => 2017-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14664
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15854554
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/854554 | INSULIN INDEPENDENCE AMONG PATIENTS WITH DIABETES UTILIZING AN OPTIMIZED HAMSTER REG3 GAMMA PEPTIDE | Dec 25, 2017 | Abandoned |
Array
(
[id] => 13339931
[patent_doc_number] => 20180221505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-09
[patent_title] => Novel Antibody And Use In Diagnosis And Therapy Of Arthropathies
[patent_app_type] => utility
[patent_app_number] => 15/844974
[patent_app_country] => US
[patent_app_date] => 2017-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8815
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15844974
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/844974 | Novel Antibody And Use In Diagnosis And Therapy Of Arthropathies | Dec 17, 2017 | Abandoned |
Array
(
[id] => 12606738
[patent_doc_number] => 20180094076
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-05
[patent_title] => Methods and Compositions for the Treatment of Autoimmune and Inflammatory Diseases
[patent_app_type] => utility
[patent_app_number] => 15/841416
[patent_app_country] => US
[patent_app_date] => 2017-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8281
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15841416
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/841416 | Methods and Compositions for the Treatment of Autoimmune and Inflammatory Diseases | Dec 13, 2017 | Abandoned |
Array
(
[id] => 18777861
[patent_doc_number] => 11819537
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-21
[patent_title] => Preventive or therapeutic method for inflammatory skin disease
[patent_app_type] => utility
[patent_app_number] => 16/345028
[patent_app_country] => US
[patent_app_date] => 2017-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 10065
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16345028
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/345028 | Preventive or therapeutic method for inflammatory skin disease | Nov 6, 2017 | Issued |
Array
(
[id] => 12233167
[patent_doc_number] => 20180066030
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-08
[patent_title] => 'MUTANT HSP70i TO PREVENT AUTOIMMUNE DISEASE'
[patent_app_type] => utility
[patent_app_number] => 15/791609
[patent_app_country] => US
[patent_app_date] => 2017-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 6714
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15791609
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/791609 | Method of treating vitiligo using mutant HSP70i | Oct 23, 2017 | Issued |
Array
(
[id] => 12603459
[patent_doc_number] => 20180092983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-05
[patent_title] => METHODS AND REAGENTS TO TREAT AUTOIMMUNE DISEASES AND ALLERGY
[patent_app_type] => utility
[patent_app_number] => 15/723173
[patent_app_country] => US
[patent_app_date] => 2017-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13477
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15723173
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/723173 | METHODS AND REAGENTS TO TREAT AUTOIMMUNE DISEASES AND ALLERGY | Oct 2, 2017 | Abandoned |
Array
(
[id] => 15432389
[patent_doc_number] => 20200030377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-30
[patent_title] => ANTIGEN-SPECIFIC IMMUNE MODULATION
[patent_app_type] => utility
[patent_app_number] => 16/335694
[patent_app_country] => US
[patent_app_date] => 2017-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7661
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16335694
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/335694 | ANTIGEN-SPECIFIC IMMUNE MODULATION | Sep 21, 2017 | Abandoned |
Array
(
[id] => 13326003
[patent_doc_number] => 20180214539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => IMMUNOGENIC PROTEIN PAS N 1 FROM BAHIA GRASS POLLEN
[patent_app_type] => utility
[patent_app_number] => 15/705059
[patent_app_country] => US
[patent_app_date] => 2017-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19814
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15705059
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/705059 | Immunogenic protein Pas n 1 from Bahia grass pollen | Sep 13, 2017 | Issued |
Array
(
[id] => 13314281
[patent_doc_number] => 20180208677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-26
[patent_title] => KLOTHO BETA
[patent_app_type] => utility
[patent_app_number] => 15/701243
[patent_app_country] => US
[patent_app_date] => 2017-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56928
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15701243
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/701243 | KLOTHO BETA | Sep 10, 2017 | Abandoned |
Array
(
[id] => 13714299
[patent_doc_number] => 20170368104
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-28
[patent_title] => INDUCTION OF TOLERANCE IN LUNG ALLOGRAFT TRANSPLANTATION
[patent_app_type] => utility
[patent_app_number] => 15/694544
[patent_app_country] => US
[patent_app_date] => 2017-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17584
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15694544
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/694544 | INDUCTION OF TOLERANCE IN LUNG ALLOGRAFT TRANSPLANTATION | Aug 31, 2017 | Abandoned |